| Identification | Back Directory | [Name]
2,6-diamino-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexanoic acid | [CAS]
32448-36-5 | [Synonyms]
Galactosylhydroxylysine
Hydroxylysine-galactose
OWGKYELXGFKIHH-ODPZDSJBSA-N
5-(galactosylhydroxy)-L-Lysine
L-Lysine, 5-(β-D-galactopyranosyloxy)-
2,6-diamino-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexanoic acid | [Molecular Formula]
C12H24N2O8 | [MDL Number]
MFCD11113132 | [MOL File]
32448-36-5.mol | [Molecular Weight]
324.33 |
| Hazard Information | Back Directory | [Uses]
Galactosylhydroxylysine is a component of bone collagen produced by post-translational glycosylation of hydroxylysine. Galactosylhydroxylysine is released during bone resorption and has been shown to be elevated in metabolic bone loss[1]. | [Definition]
ChEBI: 5-(beta-D-galactosyloxy)-L-lysine is a 5-glycosyloxy-L-lysine in which the glycosyl fragment is specified as beta-D-galactose. | [IC 50]
Human Endogenous Metabolite | [References]
[1] Leigh SD, et al. Development of an immunoassay for urinary galactosylhydroxylysine. J Immunol Methods. 1998;220(1-2):169-178. DOI:10.1016/s0022-1759(98)00159-8 |
|
|